Central Inspection Operator, IPM - Days - Fulltime - $3,000 Sign On Bonus - Starting at $22/ hour + Benefits-23 at Eli Lilly and Company

Indianapolis, Indiana, United States

Eli Lilly and Company Logo
$35,000 – $80,000Compensation
Entry Level & New GradExperience Level
Full TimeJob Type
NoVisa
Pharmaceuticals, Healthcare, ManufacturingIndustries

Requirements

  • High School diploma / GED
  • Basic math skills
  • Meet minimum qualifications outlined in the job description
  • Have/obtain work authorization in the United States

Responsibilities

  • Safely inspect high quality pharmaceutical filled syringes utilizing Lilly standards by following good manufacturing practices in controlled facilities
  • Maintain a safe work environment, work safely, adhere to parenteral plant safety policies and procedures, and support all HSE Corporate and Site Goals
  • Setup and operations in non-aseptic manufacturing processes, including the set-up, use, and/or operation of automated and semi-automated inspection machines in controlled facilities
  • Adhere to standard operating procedures and current Good Manufacturing Practices to ensure quality of product
  • Document process steps on appropriate batch documentation (paper and electronic)
  • Unloading / loading of materials for use in manufacturing areas, storage of material in appropriate storage zones and ASRS (Automated Storage Retrieval System)

Skills

Inspection
Manufacturing
Process Operation
Production
Quality Control

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI